These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2865571)

  • 21. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
    De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
    Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
    J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
    Greenberg AE; Schable CA; Sulzer AJ; Collins WE; Phuc Nguyen-Dinh
    Lancet; 1986 Aug; 2(8501):247-9. PubMed ID: 2874279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual finding of HTLV-I infection among Amazonian Amerindians.
    Barros Kanzaki LI; Casseb J
    Arch Med Res; 2007 Nov; 38(8):897-900. PubMed ID: 17923274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
    Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HTLV-III antibody testing in three Danish blood banks.
    Orskov Lindhardt B; Ulrich K; Ryder L; Dickmeiss E; Sørensen H; Jørgensen J; Jersild C; Grunnet N
    Vox Sang; 1986; 51 Suppl 1():9-14. PubMed ID: 3017006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
    Abb J
    Vox Sang; 1986; 51(3):233-5. PubMed ID: 3544497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of anti-HTLV-III/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-1985.
    Stroun J; Graf I; Frei PC
    Eur J Clin Microbiol; 1985 Dec; 4(6):583-6. PubMed ID: 3004980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
    Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
    Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
    Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
    AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III.
    Hattori T; Robert-Guroff M; Chosa T; Matsuoka M; Yamaguchi K; Ishii T; Gallo RC; Takatsuki K
    Blood; 1985 Sep; 66(3):745-7. PubMed ID: 2992645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.